Maria joined MedTech Dive as an associate editor in 2018. A D.C. area native, she holds a bachelor's degree in journalism and politics from Washington and Lee University and formerly covered politics and science news for media outlets in the U.S. and Australia.
72 articles by Maria Rachal
-
FDA clears first medical device indicated for ADHD
April 22, 2019 -
FDA orders Boston Scientific, Coloplast to pull transvaginal mesh from market
April 17, 2019 -
J&J device revenue slumps amid big bet on digital surgery
April 16, 2019 -
CMS support software mandate for imaging decisions backed by MIT study
April 12, 2019 -
FDA sounds alarm on unregulated brain injury devices
April 11, 2019 -
Australia stops short of breast implant ban
April 10, 2019 -
Pharmas see potential in digital therapeutics, but payers still on the fence: Rock Health
April 9, 2019 -
Canada, France take hard action on textured breast implants
April 5, 2019 -
New TAVR analysis adds to CMS volume-outcomes debate
April 4, 2019 -
Cryotherapy spray for COPD gets FDA breakthrough boost
April 4, 2019 -
Q1'19 digital health investments slow, but IPOs brewing
April 2, 2019 -
Bigfoot CEO talks data-driven diabetes care and becoming a service company
April 1, 2019 -
Smith & Nephew picks up pressure injury prevention device
April 1, 2019 -
FDA seeks to step up mammography oversight, info sharing
March 28, 2019 -
FDA's Day 2 of breast implant panel mulls: Who should lead on informed consent?
March 27, 2019 -
FDA experts weigh 'man-made' cancer linked to breast implants
March 26, 2019 -
With imperfect data, FDA turns to panel for way forward on breast implants
March 22, 2019 -
FDA takes hard look at breast implant safety amid fresh cancer fears
March 21, 2019 -
JDRF-backed Korean medtech gets breakthrough nod for closed loop system
March 18, 2019 -
Apple, Medtronic and more medtech to track at ACC19
March 14, 2019 -
Stryker to spend up to $220M on rotator cuff tear tech
March 14, 2019 -
NCI Director Ned Sharpless to be named FDA acting commissioner
March 12, 2019 -
NCI Director Ned Sharpless to be FDA acting commissioner
March 12, 2019 -
23andMe to gauge Type 2 diabetes risk
March 11, 2019 -
FDA advisers weigh in on HPV screens
March 7, 2019